4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001756697-26-000004
Director sold 228 shares at an average $505.87 ($115,338)
- Director acquired 130 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mesa Nilda · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-14 | Exercise or conversion : show line 1 in the form | +130 | $110.86 | $14,412 | 6,560 | D |
| 2026-09-14 | Sale : show line 2 in the form | −130 | $505.79 | $65,752 | 6,430 | D |
| 2026-09-14 | Sale : show line 3 in the form | −98 | $505.98 | $49,586 | 5,580 | D |
| Open-market sales · 228 sh · avg $505.87 · $115,338 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-14 | Exercise or conversion : show line 4 in the form Stock Option | −130 | 6,430 | D |
Loading xslF345X06/primarydocument.xml…